Clinical Trial Update: Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing esomeprazole with sodium bicarbonate versus esomeprazole alone for gastroesophageal reflux disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Esomeprazole with sodium bicarbonate (esomeprazole/sodium bicarbonate)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: WITHDRAWN